Inverse Relation of Fas-Ligand and Tumor-Infiltrating Lymphocytes in Angiosarcoma
- 1 September 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (3) , 963-970
- https://doi.org/10.1016/s0002-9440(10)61772-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand–Induced Cell DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattackDiseases of the Esophagus, 1999
- Negative Regulation of Inflammation by Fas Ligand Expression on the Vascular EndotheliumTrends in Cardiovascular Medicine, 1999
- MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in AngiosarcomasThe American Journal of Pathology, 1998
- Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivoAPMIS, 1998
- Apoptosis by Death FactorCell, 1997
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981